Page last updated: 2024-10-28

hydralazine and Cell Transformation, Neoplastic

hydralazine has been researched along with Cell Transformation, Neoplastic in 2 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrade, FO1
Nguyen, NM1
Warri, A1
Hilakivi-Clarke, L1
Queisser, N1
Amann, K1
Hey, V1
Habib, SL1
Schupp, N1

Other Studies

2 other studies available for hydralazine and Cell Transformation, Neoplastic

ArticleYear
Reversal of increased mammary tumorigenesis by valproic acid and hydralazine in offspring of dams fed high fat diet during pregnancy.
    Scientific reports, 2019, 12-30, Volume: 9, Issue:1

    Topics: Animals; Cell Transformation, Neoplastic; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Diet,

2019
Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo.
    Free radical biology & medicine, 2013, Volume: 54

    Topics: Aldosterone; Animals; Apoptosis; Blood Pressure; Cell Transformation, Neoplastic; Cells, Cultured; C

2013